Lv31
334 积分 2026-03-10 加入
新药人体首次剂量设计的技术考虑
10天前
已完结
抗肿瘤药物首次临床试验起始剂量的一般考虑
10天前
已完结
1990—2021年全球与中国60岁及以上人群高胆固醇血症的疾病负担：趋势分析与模型预测
17天前
已完结
中国ASCVD高危与极高危患者降脂治疗状况分析
18天前
已完结
Beyond conventional treatment: ASGR1 Leading the new era of hypercholesterolemia management
20天前
已完结
ASGR1 inhibitors, inflammation, and heart failure: A Mendelian randomization analysis
24天前
已完结
Effectiveness and safety of the SREBP1/2 inhibitor, fatostatin, in a preclinical model of metabolic dysfunction-associated steatotic liver disease progression
1个月前
已完结
Physiological and pathological roles of lipogenesis
1个月前
已完结
Momordin Ic targets SREBP1 to disrupt lipid homeostasis and trigger synergistic apoptosis-ferroptosis in triple-negative breast cancer
1个月前
已完结
Fumarate hydratase ameliorates pressure overload induced cardiac remodeling by controlling Elovl7-mediated biosynthesis of unsaturated fatty acids
1个月前
已完结
皖公网安备34019202002308
